Private finance: Ablaze Pharmaceuticals, knok, Viebeg Technologies, Neurophth Therapeutics, iSTAR Medical

Belgium: iSTAR Medical, a medical technology company, has signed a €20m (US$22.7m) quasi-equity financing agreement with the European Investment Bank (EIB). iSTAR Medical is developing minimally-invasive implants for glaucoma surgery (MIGS). Glaucoma is the leading cause of irreversible blindness. The EIB’s non-dilutive financing will support its R&D and product development activities in further clinical trials, regulatory…

You must be a HMI Subscriber to view this content.

Subscribe Now »